

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.84590570 |
| 2 | cell adhesion mediated by integrin (GO:0033627) | 4.77996117 |
| 3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.74655596 |
| 4 | wound healing, spreading of epidermal cells (GO:0035313) | 4.55099531 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50127313 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.50127313 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50127313 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50127313 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50127313 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.50127313 |
| 11 | regulation of mononuclear cell migration (GO:0071675) | 4.30504963 |
| 12 | regulation of chronic inflammatory response (GO:0002676) | 4.19055199 |
| 13 | T-helper 1 type immune response (GO:0042088) | 4.15829621 |
| 14 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.97662290 |
| 15 | chronic inflammatory response (GO:0002544) | 3.92356087 |
| 16 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.82336637 |
| 17 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.82020047 |
| 18 | germinal center formation (GO:0002467) | 3.79410961 |
| 19 | response to peptidoglycan (GO:0032494) | 3.78949651 |
| 20 | regulation of chemokine biosynthetic process (GO:0045073) | 3.72473561 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72331584 |
| 22 | response to protozoan (GO:0001562) | 3.71382352 |
| 23 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.70144166 |
| 24 | regulation of monocyte chemotaxis (GO:0090025) | 3.69770327 |
| 25 | defense response to protozoan (GO:0042832) | 3.68009717 |
| 26 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.67554610 |
| 27 | cellular response to interferon-alpha (GO:0035457) | 3.67445889 |
| 28 | chondrocyte proliferation (GO:0035988) | 3.66870495 |
| 29 | wound healing, spreading of cells (GO:0044319) | 3.61453399 |
| 30 | positive regulation of type 2 immune response (GO:0002830) | 3.61338109 |
| 31 | negative regulation of fatty acid transport (GO:2000192) | 3.60716761 |
| 32 | collagen fibril organization (GO:0030199) | 3.60010380 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.58952402 |
| 34 | regulation of podosome assembly (GO:0071801) | 3.55668617 |
| 35 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.54714558 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.51356034 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.50231727 |
| 38 | type I interferon signaling pathway (GO:0060337) | 3.50231727 |
| 39 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.46161929 |
| 40 | response to type I interferon (GO:0034340) | 3.45908993 |
| 41 | * positive regulation of acute inflammatory response (GO:0002675) | 3.44811441 |
| 42 | low-density lipoprotein particle clearance (GO:0034383) | 3.44061171 |
| 43 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.43967925 |
| 44 | endodermal cell differentiation (GO:0035987) | 3.43520306 |
| 45 | regulation of T-helper cell differentiation (GO:0045622) | 3.36935927 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 3.35593586 |
| 47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.34641594 |
| 48 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.34610061 |
| 49 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.33821754 |
| 50 | cellular response to lipopolysaccharide (GO:0071222) | 3.32172533 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29777248 |
| 52 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.28261638 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.26267691 |
| 54 | cellular response to molecule of bacterial origin (GO:0071219) | 3.25891509 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.25730048 |
| 56 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.25200763 |
| 57 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.24182023 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.21621596 |
| 59 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 3.20587682 |
| 60 | * positive regulation of heat generation (GO:0031652) | 3.17821219 |
| 61 | * regulation of NF-kappaB import into nucleus (GO:0042345) | 3.15060136 |
| 62 | macrophage activation involved in immune response (GO:0002281) | 3.14206599 |
| 63 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.14146283 |
| 64 | * regulation of fever generation (GO:0031620) | 3.10158420 |
| 65 | negative regulation of lipid storage (GO:0010888) | 3.09282652 |
| 66 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.09141372 |
| 67 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.08557039 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07959824 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.07008566 |
| 70 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.05956022 |
| 71 | regulation of growth of symbiont in host (GO:0044126) | 3.05956022 |
| 72 | negative regulation of growth of symbiont in host (GO:0044130) | 3.05956022 |
| 73 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.05956022 |
| 74 | regulation of interleukin-12 production (GO:0032655) | 3.05835852 |
| 75 | regulation of type 2 immune response (GO:0002828) | 3.05609495 |
| 76 | positive regulation of interleukin-17 production (GO:0032740) | 3.05581837 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.04714867 |
| 78 | positive regulation of chemokine production (GO:0032722) | 3.03979244 |
| 79 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.01723236 |
| 80 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.97509374 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97262902 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96604347 |
| 83 | regulation of immunoglobulin secretion (GO:0051023) | 2.94474828 |
| 84 | regulation of macrophage cytokine production (GO:0010935) | 2.94098554 |
| 85 | apoptotic cell clearance (GO:0043277) | 2.93885085 |
| 86 | regulation of interleukin-6 production (GO:0032675) | 2.93305850 |
| 87 | immunoglobulin mediated immune response (GO:0016064) | 2.92736285 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.92091474 |
| 89 | positive regulation of interleukin-10 production (GO:0032733) | 2.91713199 |
| 90 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91195979 |
| 91 | positive regulation of interferon-beta production (GO:0032728) | 2.89688037 |
| 92 | neutrophil mediated immunity (GO:0002446) | 2.88464218 |
| 93 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.88236293 |
| 94 | cellular response to biotic stimulus (GO:0071216) | 2.87610409 |
| 95 | regulation of integrin activation (GO:0033623) | 2.87274338 |
| 96 | * regulation of heat generation (GO:0031650) | 2.87223800 |
| 97 | cellular extravasation (GO:0045123) | 2.86005483 |
| 98 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.85966577 |
| 99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84644243 |
| 100 | positive regulation of p38MAPK cascade (GO:1900745) | 2.84350364 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83155805 |
| 102 | response to host immune response (GO:0052572) | 2.83155805 |
| 103 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82647910 |
| 104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82429644 |
| 105 | positive regulation of macrophage cytokine production (GO:0060907) | 2.81970965 |
| 106 | * positive regulation of transcription factor import into nucleus (GO:0042993) | 2.81356172 |
| 107 | regulation of vitamin metabolic process (GO:0030656) | 2.80634404 |
| 108 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.80272947 |
| 109 | axon extension involved in axon guidance (GO:0048846) | 2.80272947 |
| 110 | macrophage activation (GO:0042116) | 2.80028164 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 2.79042473 |
| 112 | cellular response to nicotine (GO:0071316) | 2.77869072 |
| 113 | cellular response to vitamin D (GO:0071305) | 2.77367412 |
| 114 | regulation of plasminogen activation (GO:0010755) | 2.77352192 |
| 115 | neutrophil activation (GO:0042119) | 2.77193062 |
| 116 | natural killer cell mediated immunity (GO:0002228) | 2.76913365 |
| 117 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.76913365 |
| 118 | regulation of macrophage chemotaxis (GO:0010758) | 2.75631201 |
| 119 | negative regulation of interleukin-17 production (GO:0032700) | 2.74895985 |
| 120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72237785 |
| 121 | positive regulation of interleukin-6 production (GO:0032755) | 2.71933747 |
| 122 | regulation of interleukin-17 production (GO:0032660) | 2.71923353 |
| 123 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.71275451 |
| 124 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.70338212 |
| 125 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.69900688 |
| 126 | negative regulation of organic acid transport (GO:0032891) | 2.69493082 |
| 127 | response to interferon-alpha (GO:0035455) | 2.69352991 |
| 128 | myeloid cell homeostasis (GO:0002262) | 2.68355697 |
| 129 | granulocyte activation (GO:0036230) | 2.66619474 |
| 130 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.66564613 |
| 131 | skin morphogenesis (GO:0043589) | 2.65482753 |
| 132 | response to host (GO:0075136) | 2.64810752 |
| 133 | response to host defenses (GO:0052200) | 2.64810752 |
| 134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64810752 |
| 135 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.64362176 |
| 136 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.64080926 |
| 137 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.60472071 |
| 138 | I-kappaB phosphorylation (GO:0007252) | 2.60383337 |
| 139 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.60154947 |
| 140 | NIK/NF-kappaB signaling (GO:0038061) | 2.60054940 |
| 141 | negative regulation of bone mineralization (GO:0030502) | 2.59980629 |
| 142 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58594464 |
| 143 | positive regulation of macrophage activation (GO:0043032) | 2.56344626 |
| 144 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.55160866 |
| 145 | positive regulation of osteoblast proliferation (GO:0033690) | 2.55138945 |
| 146 | * positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.54796834 |
| 147 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.54638644 |
| 148 | substrate-dependent cell migration (GO:0006929) | 2.53321905 |
| 149 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.53035843 |
| 150 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.52220697 |
| 151 | leukocyte aggregation (GO:0070486) | 2.51708541 |
| 152 | monocyte chemotaxis (GO:0002548) | 2.48676233 |
| 153 | respiratory burst (GO:0045730) | 2.48255171 |
| 154 | eosinophil chemotaxis (GO:0048245) | 2.48221486 |
| 155 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.47841551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.21786103 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.69344171 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.23833642 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21241375 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.14687390 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.08274041 |
| 7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.68836317 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.50208336 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.40564105 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.38395642 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.35614074 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.07231898 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00277457 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83515906 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.69687379 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69000557 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63479230 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55865992 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45924591 |
| 20 | CJUN_26792858_Chip-Seq_BT549_Human | 2.22275178 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.21493382 |
| 22 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.20198397 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14998751 |
| 24 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.13530542 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.10364880 |
| 26 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.09376147 |
| 27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.09376147 |
| 28 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.03139483 |
| 29 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.93475409 |
| 30 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.93475409 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89221299 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88907365 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.87050670 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80333627 |
| 35 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77810790 |
| 36 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.74046781 |
| 37 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.69593992 |
| 38 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.66592355 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.66425899 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65308896 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65193322 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64016062 |
| 43 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62550973 |
| 44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60248608 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59282086 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59069588 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.57548007 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56875461 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54742490 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53668696 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53405939 |
| 52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51191440 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51094066 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46673447 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44100150 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40054994 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37888269 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35682456 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35321925 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34794012 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31059414 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29730436 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24772253 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.24441013 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23028295 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22893118 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22157836 |
| 68 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.18055220 |
| 69 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.18055220 |
| 70 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.18055220 |
| 71 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16977738 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16064991 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15449490 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15409350 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13184297 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11975733 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11689221 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10170029 |
| 79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09733532 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09226201 |
| 81 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.08650689 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08343174 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07700008 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07124549 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06409628 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05831764 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05560926 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05306697 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03583001 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02768126 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02134800 |
| 92 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.01743394 |
| 93 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01392728 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99594682 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99315011 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99267888 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98755945 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97950063 |
| 99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97538641 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 0.97531765 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97477025 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97201414 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96599697 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95821395 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95027664 |
| 106 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94134281 |
| 107 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93866017 |
| 108 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93078977 |
| 109 | MYB_26560356_Chip-Seq_TH1_Human | 0.92667081 |
| 110 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91362216 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89902739 |
| 112 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88873715 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88857581 |
| 114 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88757684 |
| 115 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87243677 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 0.86193784 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86117461 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85351513 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84906260 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84798531 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83122383 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82940890 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82589600 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80966456 |
| 125 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80821991 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78847009 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78231236 |
| 128 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78063247 |
| 129 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77497409 |
| 130 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.76996529 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.73098098 |
| 132 | MAF_26560356_Chip-Seq_TH1_Human | 0.72593166 |
| 133 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.72163812 |
| 134 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70347456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.82647523 |
| 2 | MP0005275_abnormal_skin_tensile | 3.07588941 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.94097653 |
| 4 | * MP0010352_gastrointestinal_tract_polyps | 2.69748952 |
| 5 | MP0009785_altered_susceptibility_to | 2.65254972 |
| 6 | * MP0003436_decreased_susceptibility_to | 2.53048948 |
| 7 | MP0003724_increased_susceptibility_to | 2.47305403 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.44054694 |
| 9 | MP0006082_CNS_inflammation | 2.42199965 |
| 10 | * MP0001533_abnormal_skeleton_physiology | 2.32753010 |
| 11 | MP0003279_aneurysm | 2.29319174 |
| 12 | MP0003091_abnormal_cell_migration | 2.27172290 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.26811965 |
| 14 | * MP0005023_abnormal_wound_healing | 2.22086214 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.12554092 |
| 16 | * MP0002419_abnormal_innate_immunity | 2.10312483 |
| 17 | MP0004947_skin_inflammation | 2.09903514 |
| 18 | MP0005451_abnormal_body_composition | 2.08261189 |
| 19 | MP0005623_abnormal_meninges_morphology | 2.08096230 |
| 20 | MP0001958_emphysema | 2.07909237 |
| 21 | MP0001348_abnormal_lacrimal_gland | 2.07520651 |
| 22 | MP0003448_altered_tumor_morphology | 2.07318898 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.06443473 |
| 24 | MP0000343_altered_response_to | 2.02784336 |
| 25 | * MP0005000_abnormal_immune_tolerance | 2.01722438 |
| 26 | MP0004510_myositis | 2.00675042 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.99128420 |
| 28 | MP0002933_joint_inflammation | 1.94133170 |
| 29 | MP0001853_heart_inflammation | 1.86085708 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.85718713 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.81108876 |
| 32 | * MP0005390_skeleton_phenotype | 1.77277870 |
| 33 | MP0005387_immune_system_phenotype | 1.76312596 |
| 34 | MP0001790_abnormal_immune_system | 1.76312596 |
| 35 | MP0009840_abnormal_foam_cell | 1.74703184 |
| 36 | * MP0003303_peritoneal_inflammation | 1.72849544 |
| 37 | * MP0005025_abnormal_response_to | 1.65103063 |
| 38 | * MP0002332_abnormal_exercise_endurance | 1.64843152 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.64482431 |
| 40 | * MP0005164_abnormal_response_to | 1.64468713 |
| 41 | MP0000685_abnormal_immune_system | 1.63759331 |
| 42 | MP0009278_abnormal_bone_marrow | 1.63338029 |
| 43 | MP0002254_reproductive_system_inflammat | 1.62894895 |
| 44 | MP0009764_decreased_sensitivity_to | 1.60872682 |
| 45 | MP0002295_abnormal_pulmonary_circulatio | 1.55449370 |
| 46 | MP0002282_abnormal_trachea_morphology | 1.54494394 |
| 47 | * MP0002452_abnormal_antigen_presenting | 1.54157131 |
| 48 | MP0001542_abnormal_bone_strength | 1.51889056 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.50239310 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.50165494 |
| 51 | MP0001243_abnormal_dermal_layer | 1.46840459 |
| 52 | MP0000858_altered_metastatic_potential | 1.45547517 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.44737421 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.43609225 |
| 55 | MP0002405_respiratory_system_inflammati | 1.37924152 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.37734395 |
| 57 | MP0002896_abnormal_bone_mineralization | 1.35787743 |
| 58 | * MP0002723_abnormal_immune_serum | 1.34768880 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.33526892 |
| 60 | MP0005508_abnormal_skeleton_morphology | 1.33256829 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.30476666 |
| 62 | MP0002006_tumorigenesis | 1.26885046 |
| 63 | MP0003690_abnormal_glial_cell | 1.26418652 |
| 64 | MP0002060_abnormal_skin_morphology | 1.25003144 |
| 65 | * MP0001845_abnormal_inflammatory_respons | 1.24865491 |
| 66 | * MP0003075_altered_response_to | 1.24048521 |
| 67 | MP0004858_abnormal_nervous_system | 1.23930995 |
| 68 | * MP0003795_abnormal_bone_structure | 1.21181650 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.18716708 |
| 70 | MP0004272_abnormal_basement_membrane | 1.18329878 |
| 71 | * MP0001800_abnormal_humoral_immune | 1.15902018 |
| 72 | MP0009384_cardiac_valve_regurgitation | 1.14453793 |
| 73 | MP0006054_spinal_hemorrhage | 1.13671959 |
| 74 | * MP0000716_abnormal_immune_system | 1.13247202 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.12904266 |
| 76 | MP0000733_abnormal_muscle_development | 1.12792640 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.10726012 |
| 78 | * MP0001819_abnormal_immune_cell | 1.09880437 |
| 79 | MP0001501_abnormal_sleep_pattern | 1.09456573 |
| 80 | MP0003828_pulmonary_edema | 1.09287631 |
| 81 | * MP0002113_abnormal_skeleton_development | 1.07734991 |
| 82 | MP0002115_abnormal_skeleton_extremities | 1.07576820 |
| 83 | * MP0005166_decreased_susceptibility_to | 1.06680083 |
| 84 | * MP0002420_abnormal_adaptive_immunity | 1.06628771 |
| 85 | MP0003195_calcinosis | 1.05503352 |
| 86 | * MP0010155_abnormal_intestine_physiology | 1.05383821 |
| 87 | MP0008469_abnormal_protein_level | 1.05348961 |
| 88 | * MP0009763_increased_sensitivity_to | 1.04388932 |
| 89 | MP0000163_abnormal_cartilage_morphology | 1.02349736 |
| 90 | * MP0009765_abnormal_xenobiotic_induced | 0.99986888 |
| 91 | * MP0005464_abnormal_platelet_physiology | 0.99160503 |
| 92 | MP0010307_abnormal_tumor_latency | 0.98890831 |
| 93 | MP0005310_abnormal_salivary_gland | 0.96845467 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.95821716 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.95821716 |
| 96 | MP0005671_abnormal_response_to | 0.94660692 |
| 97 | MP0000604_amyloidosis | 0.94022537 |
| 98 | * MP0002398_abnormal_bone_marrow | 0.93347242 |
| 99 | MP0008260_abnormal_autophagy | 0.91175103 |
| 100 | * MP0008004_abnormal_stomach_pH | 0.87629854 |
| 101 | MP0004134_abnormal_chest_morphology | 0.86847112 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.86522667 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.84540760 |
| 104 | * MP0000249_abnormal_blood_vessel | 0.84117720 |
| 105 | * MP0002429_abnormal_blood_cell | 0.84071385 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 0.81412704 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.78742813 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.74898241 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.74684404 |
| 110 | * MP0002168_other_aberrant_phenotype | 0.73172692 |
| 111 | MP0001851_eye_inflammation | 0.73087289 |
| 112 | MP0000920_abnormal_myelination | 0.72876094 |
| 113 | * MP0002722_abnormal_immune_system | 0.72685328 |
| 114 | MP0000627_abnormal_mammary_gland | 0.72038671 |
| 115 | MP0002133_abnormal_respiratory_system | 0.71603203 |
| 116 | MP0005388_respiratory_system_phenotype | 0.71603203 |
| 117 | MP0004883_abnormal_blood_vessel | 0.70902994 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.69601097 |
| 119 | * MP0001216_abnormal_epidermal_layer | 0.69318659 |
| 120 | MP0005165_increased_susceptibility_to | 0.69105773 |
| 121 | * MP0000689_abnormal_spleen_morphology | 0.68115037 |
| 122 | MP0003763_abnormal_thymus_physiology | 0.67984568 |
| 123 | MP0002138_abnormal_hepatobiliary_system | 0.67437086 |
| 124 | MP0005595_abnormal_vascular_smooth | 0.67365546 |
| 125 | * MP0005535_abnormal_body_temperature | 0.66965243 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.66832145 |
| 127 | * MP0001614_abnormal_blood_vessel | 0.65324702 |
| 128 | MP0002128_abnormal_blood_circulation | 0.63991618 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62972043 |
| 130 | * MP0001663_abnormal_digestive_system | 0.62967941 |
| 131 | MP0003950_abnormal_plasma_membrane | 0.60436208 |
| 132 | MP0003646_muscle_fatigue | 0.59993256 |
| 133 | * MP0008874_decreased_physiological_sensi | 0.57914310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.39562116 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.20666889 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.20666889 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.20666889 |
| 5 | Peritonitis (HP:0002586) | 4.77444208 |
| 6 | Keratoconjunctivitis sicca (HP:0001097) | 4.46130989 |
| 7 | Protrusio acetabuli (HP:0003179) | 4.36768348 |
| 8 | Cervical subluxation (HP:0003308) | 4.22637981 |
| 9 | Aortic dissection (HP:0002647) | 4.11721969 |
| 10 | Keratoconjunctivitis (HP:0001096) | 4.05573870 |
| 11 | Epiphyseal dysplasia (HP:0002656) | 4.00004622 |
| 12 | Aortic aneurysm (HP:0004942) | 3.56944340 |
| 13 | Gangrene (HP:0100758) | 3.53818893 |
| 14 | Increased density of long bones (HP:0006392) | 3.50265733 |
| 15 | Cupped ribs (HP:0000887) | 3.45468527 |
| 16 | Loss of speech (HP:0002371) | 3.43280816 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.40955513 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.36527006 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.35894444 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.34425903 |
| 21 | Atrophic scars (HP:0001075) | 3.19709472 |
| 22 | Amyloidosis (HP:0011034) | 3.18754549 |
| 23 | Vasculitis (HP:0002633) | 3.18612854 |
| 24 | Papilledema (HP:0001085) | 3.10724788 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.06971087 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 3.05256806 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.05256806 |
| 28 | Disinhibition (HP:0000734) | 3.04887151 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.03119857 |
| 30 | Radial bowing (HP:0002986) | 3.02965296 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.01130535 |
| 32 | Hemoptysis (HP:0002105) | 3.01071457 |
| 33 | Dilatation of the ascending aorta (HP:0005111) | 2.97702890 |
| 34 | Flat acetabular roof (HP:0003180) | 2.94903870 |
| 35 | Neonatal short-limb short stature (HP:0008921) | 2.94295551 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.90739243 |
| 37 | Hypoplastic ischia (HP:0003175) | 2.90209914 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.85184538 |
| 39 | Arterial thrombosis (HP:0004420) | 2.83883184 |
| 40 | Absent frontal sinuses (HP:0002688) | 2.83837441 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.79933631 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78258373 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78258373 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78258373 |
| 45 | Short nail (HP:0001799) | 2.78122754 |
| 46 | Osteoarthritis (HP:0002758) | 2.73243744 |
| 47 | Vitreoretinal degeneration (HP:0000655) | 2.73150791 |
| 48 | Genu recurvatum (HP:0002816) | 2.70444898 |
| 49 | Hematochezia (HP:0002573) | 2.70380987 |
| 50 | Anorexia (HP:0002039) | 2.68094850 |
| 51 | Episodic fever (HP:0001954) | 2.63132542 |
| 52 | Shallow orbits (HP:0000586) | 2.62759697 |
| 53 | Fused cervical vertebrae (HP:0002949) | 2.62036627 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61581244 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.61581244 |
| 56 | Nuclear cataract (HP:0100018) | 2.60466702 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.60442138 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57994055 |
| 59 | Ulnar bowing (HP:0003031) | 2.57294933 |
| 60 | Coxa vara (HP:0002812) | 2.55805669 |
| 61 | Irregular epiphyses (HP:0010582) | 2.55169017 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.53640355 |
| 63 | Increased IgE level (HP:0003212) | 2.47852206 |
| 64 | Soft skin (HP:0000977) | 2.44100079 |
| 65 | Abnormality of the ischium (HP:0003174) | 2.43694338 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.41956191 |
| 67 | Orchitis (HP:0100796) | 2.41628792 |
| 68 | Increased IgM level (HP:0003496) | 2.40245474 |
| 69 | Wormian bones (HP:0002645) | 2.40053211 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39398731 |
| 71 | Myocardial infarction (HP:0001658) | 2.39026249 |
| 72 | Urticaria (HP:0001025) | 2.38037650 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.37469765 |
| 74 | Increased serum ferritin (HP:0003281) | 2.37247263 |
| 75 | Recurrent skin infections (HP:0001581) | 2.36508645 |
| 76 | Small epiphyses (HP:0010585) | 2.35281859 |
| 77 | Cerebral aneurysm (HP:0004944) | 2.33238021 |
| 78 | Parakeratosis (HP:0001036) | 2.32520124 |
| 79 | Fragile skin (HP:0001030) | 2.31852672 |
| 80 | Abnormality of the vertebral endplates (HP:0005106) | 2.31686711 |
| 81 | Polyneuropathy (HP:0001271) | 2.31639668 |
| 82 | Tibial bowing (HP:0002982) | 2.31563291 |
| 83 | Metaphyseal cupping (HP:0003021) | 2.31025593 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 2.30366641 |
| 85 | Spinal cord compression (HP:0002176) | 2.29650281 |
| 86 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.29290892 |
| 87 | Gingivitis (HP:0000230) | 2.28775676 |
| 88 | Mitral valve prolapse (HP:0001634) | 2.28705588 |
| 89 | Mesomelia (HP:0003027) | 2.28086911 |
| 90 | Beaking of vertebral bodies (HP:0004568) | 2.27731394 |
| 91 | Stomatitis (HP:0010280) | 2.26306881 |
| 92 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.25827461 |
| 93 | Tetraparesis (HP:0002273) | 2.25790811 |
| 94 | Bowing of the arm (HP:0006488) | 2.25676629 |
| 95 | Bowed forearm bones (HP:0003956) | 2.25676629 |
| 96 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.23042204 |
| 97 | Recurrent fungal infections (HP:0002841) | 2.22979734 |
| 98 | Glomerulopathy (HP:0100820) | 2.22341741 |
| 99 | Flat capital femoral epiphysis (HP:0003370) | 2.21257173 |
| 100 | Apathy (HP:0000741) | 2.21048752 |
| 101 | Syringomyelia (HP:0003396) | 2.20733594 |
| 102 | Spinal cord lesions (HP:0100561) | 2.20733594 |
| 103 | Encephalitis (HP:0002383) | 2.20455176 |
| 104 | Thin bony cortex (HP:0002753) | 2.20423201 |
| 105 | Vertigo (HP:0002321) | 2.20415612 |
| 106 | Leukocytosis (HP:0001974) | 2.19776689 |
| 107 | Abnormality of the acetabulum (HP:0003170) | 2.18655296 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 2.18624495 |
| 109 | Keratitis (HP:0000491) | 2.18164696 |
| 110 | Abnormality of the endocardium (HP:0004306) | 2.18119372 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16497174 |
| 112 | Myositis (HP:0100614) | 2.16218004 |
| 113 | Platyspondyly (HP:0000926) | 2.15099674 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14401631 |
| 115 | Obstructive lung disease (HP:0006536) | 2.14401631 |
| 116 | Mediastinal lymphadenopathy (HP:0100721) | 2.14349575 |
| 117 | Joint swelling (HP:0001386) | 2.12672981 |
| 118 | Overgrowth (HP:0001548) | 2.12638983 |
| 119 | T lymphocytopenia (HP:0005403) | 2.12351849 |
| 120 | Mutism (HP:0002300) | 2.12306565 |
| 121 | Blue sclerae (HP:0000592) | 2.10815161 |
| 122 | Ectopia lentis (HP:0001083) | 2.10417154 |
| 123 | Diminished motivation (HP:0000745) | 2.09944539 |
| 124 | Abnormality of macrophages (HP:0004311) | 2.09879313 |
| 125 | Recurrent viral infections (HP:0004429) | 2.09819434 |
| 126 | Acne (HP:0001061) | 2.08692483 |
| 127 | Abnormal vertebral ossification (HP:0100569) | 2.08322975 |
| 128 | Pulmonary embolism (HP:0002204) | 2.08038595 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 2.06198851 |
| 130 | Abnormal foot bone ossification (HP:0010675) | 2.05855699 |
| 131 | Meningitis (HP:0001287) | 2.05467385 |
| 132 | Broad face (HP:0000283) | 2.05208367 |
| 133 | Hydroxyprolinuria (HP:0003080) | 2.02817170 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 2.02817170 |
| 135 | Abnormality of T cell number (HP:0011839) | 2.02552021 |
| 136 | Flattened epiphyses (HP:0003071) | 2.01845747 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 2.01205950 |
| 138 | Broad ribs (HP:0000885) | 2.01052429 |
| 139 | Optic neuritis (HP:0100653) | 2.00921039 |
| 140 | Retrobulbar optic neuritis (HP:0100654) | 2.00921039 |
| 141 | Axonal loss (HP:0003447) | 2.00441712 |
| 142 | Abnormality of the nasal septum (HP:0000419) | 2.00208056 |
| 143 | Limited elbow extension (HP:0001377) | 2.00193621 |
| 144 | Glomerulonephritis (HP:0000099) | 1.98703547 |
| 145 | Persistence of primary teeth (HP:0006335) | 1.98118408 |
| 146 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97556168 |
| 147 | Abnormality of the odontoid process (HP:0003310) | 1.97249669 |
| 148 | Joint stiffness (HP:0001387) | 1.97102531 |
| 149 | Thoracolumbar scoliosis (HP:0002944) | 1.96709927 |
| 150 | Autoimmune thrombocytopenia (HP:0001973) | 1.96525466 |
| 151 | Abnormality of the calcaneus (HP:0008364) | 1.95839907 |
| 152 | Progressive neurologic deterioration (HP:0002344) | 1.92849193 |
| 153 | Abnormality of the frontal sinuses (HP:0002687) | 1.91986353 |
| 154 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90657833 |
| 155 | Hypoplasia of the odontoid process (HP:0003311) | 1.88755401 |
| 156 | Aseptic necrosis (HP:0010885) | 1.88680902 |
| 157 | Spondylolisthesis (HP:0003302) | 1.88149685 |
| 158 | Ankle contracture (HP:0006466) | 1.87906908 |
| 159 | Ovoid vertebral bodies (HP:0003300) | 1.87741673 |
| 160 | Nausea (HP:0002018) | 1.87591444 |
| 161 | Biconcave vertebral bodies (HP:0004586) | 1.87367014 |
| 162 | Abnormality of the lumbar spine (HP:0100712) | 1.86432802 |
| 163 | Arthralgia (HP:0002829) | 1.86392925 |
| 164 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.85576111 |
| 165 | Basal ganglia calcification (HP:0002135) | 1.85151207 |
| 166 | Thick nail (HP:0001805) | 1.84823266 |
| 167 | Abnormal tarsal ossification (HP:0008369) | 1.84533817 |
| 168 | Abnormal ossification of hand bones (HP:0005921) | 1.83774997 |
| 169 | Chest pain (HP:0100749) | 1.83379073 |
| 170 | Abnormality of carpal bone ossification (HP:0006257) | 1.82218286 |
| 171 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81876922 |
| 172 | Vertebral hypoplasia (HP:0008417) | 1.81553558 |
| 173 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.81553558 |
| 174 | Increased connective tissue (HP:0009025) | 1.81325672 |
| 175 | Abnormality of iron homeostasis (HP:0011031) | 1.81039804 |
| 176 | Amaurosis fugax (HP:0100576) | 1.80745091 |
| 177 | Asymmetric septal hypertrophy (HP:0001670) | 1.80255243 |
| 178 | Metaphyseal irregularity (HP:0003025) | 1.78119815 |
| 179 | Alveolar cell carcinoma (HP:0006519) | 1.76643476 |
| 180 | Neuronal loss in central nervous system (HP:0002529) | 1.76624519 |
| 181 | Malnutrition (HP:0004395) | 1.72865292 |
| 182 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72168561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 3.83670631 |
| 2 | MAP3K14 | 3.61789688 |
| 3 | TTN | 3.34263019 |
| 4 | TBK1 | 3.09546268 |
| 5 | ERN1 | 2.89770226 |
| 6 | PBK | 2.88724238 |
| 7 | PIM2 | 2.56625143 |
| 8 | PRPF4B | 2.49225585 |
| 9 | BMPR2 | 2.45416717 |
| 10 | GRK7 | 2.45152845 |
| 11 | IRAK3 | 2.33752345 |
| 12 | MAP3K3 | 2.29670531 |
| 13 | EPHA2 | 2.11631167 |
| 14 | IRAK1 | 2.09246368 |
| 15 | IRAK2 | 2.03164836 |
| 16 | IKBKB | 2.01880579 |
| 17 | RPS6KA4 | 1.95540386 |
| 18 | RIPK4 | 1.79567213 |
| 19 | BMX | 1.79097640 |
| 20 | TESK1 | 1.76751976 |
| 21 | TYK2 | 1.73374498 |
| 22 | MAP4K1 | 1.73157536 |
| 23 | IKBKE | 1.69363360 |
| 24 | JAK3 | 1.68741721 |
| 25 | TRIB3 | 1.67904158 |
| 26 | PAK2 | 1.58420881 |
| 27 | BLK | 1.56738264 |
| 28 | CSK | 1.52836501 |
| 29 | EPHB1 | 1.48097992 |
| 30 | PIK3CG | 1.47705994 |
| 31 | CDC42BPA | 1.46468330 |
| 32 | MYLK | 1.46051883 |
| 33 | TRPM7 | 1.43983401 |
| 34 | JAK1 | 1.43674805 |
| 35 | MAP3K13 | 1.41803975 |
| 36 | CHUK | 1.38315779 |
| 37 | LATS1 | 1.37311086 |
| 38 | EPHA3 | 1.34548548 |
| 39 | MAP3K1 | 1.34326619 |
| 40 | STK3 | 1.30339020 |
| 41 | LRRK2 | 1.29424422 |
| 42 | PDGFRA | 1.27152918 |
| 43 | STK10 | 1.25359544 |
| 44 | ERBB3 | 1.23422862 |
| 45 | MOS | 1.23285967 |
| 46 | TAOK3 | 1.14375202 |
| 47 | ABL2 | 1.14000185 |
| 48 | IRAK4 | 1.08443532 |
| 49 | PLK2 | 1.08054985 |
| 50 | FGR | 1.06291563 |
| 51 | DMPK | 1.05126071 |
| 52 | PAK3 | 1.04900995 |
| 53 | KIT | 1.03683302 |
| 54 | LIMK1 | 1.02430236 |
| 55 | PTK2 | 1.01951966 |
| 56 | PIM1 | 0.98066667 |
| 57 | ERBB4 | 0.97283740 |
| 58 | RIPK1 | 0.96493961 |
| 59 | PRKG2 | 0.92313005 |
| 60 | EPHB2 | 0.92303905 |
| 61 | NEK9 | 0.91381052 |
| 62 | ARAF | 0.90003152 |
| 63 | PKN2 | 0.86444284 |
| 64 | MAP3K5 | 0.85042071 |
| 65 | FER | 0.84864116 |
| 66 | HCK | 0.83906430 |
| 67 | PTK6 | 0.82706297 |
| 68 | ADRBK2 | 0.82643234 |
| 69 | NUAK1 | 0.82236619 |
| 70 | LATS2 | 0.80449592 |
| 71 | PIK3CA | 0.78815563 |
| 72 | SIK3 | 0.74791129 |
| 73 | NME2 | 0.72827149 |
| 74 | FGFR3 | 0.72450980 |
| 75 | PDGFRB | 0.72013864 |
| 76 | MARK3 | 0.71051665 |
| 77 | MST1R | 0.70857555 |
| 78 | EGFR | 0.69719678 |
| 79 | MAP2K3 | 0.68891621 |
| 80 | ABL1 | 0.67578274 |
| 81 | CLK1 | 0.67283285 |
| 82 | SYK | 0.65030992 |
| 83 | INSR | 0.65013877 |
| 84 | MATK | 0.64926056 |
| 85 | MST4 | 0.64345586 |
| 86 | * LYN | 0.63239681 |
| 87 | MAP2K1 | 0.60508310 |
| 88 | PTK2B | 0.60366489 |
| 89 | MET | 0.57729345 |
| 90 | FGFR4 | 0.56456179 |
| 91 | TAOK1 | 0.56300642 |
| 92 | TAOK2 | 0.56119131 |
| 93 | RAF1 | 0.55570077 |
| 94 | PAK4 | 0.54798112 |
| 95 | STK38L | 0.54600041 |
| 96 | DAPK3 | 0.53861192 |
| 97 | DYRK3 | 0.53168427 |
| 98 | GSK3A | 0.52925009 |
| 99 | ZAP70 | 0.51109713 |
| 100 | CDK6 | 0.50939582 |
| 101 | TYRO3 | 0.50644907 |
| 102 | MAPK7 | 0.49357008 |
| 103 | TXK | 0.49154033 |
| 104 | MAPK4 | 0.47325804 |
| 105 | HIPK2 | 0.47138169 |
| 106 | CSF1R | 0.45357999 |
| 107 | MAPKAPK2 | 0.45043542 |
| 108 | FGFR1 | 0.44712814 |
| 109 | FRK | 0.44350333 |
| 110 | BTK | 0.43786755 |
| 111 | STK24 | 0.43022551 |
| 112 | ROCK1 | 0.43019160 |
| 113 | JAK2 | 0.42016531 |
| 114 | ACVR1B | 0.41899265 |
| 115 | PAK1 | 0.40949526 |
| 116 | LCK | 0.40262586 |
| 117 | TGFBR2 | 0.40244804 |
| 118 | KSR2 | 0.40172739 |
| 119 | EIF2AK2 | 0.39670840 |
| 120 | SIK1 | 0.38923303 |
| 121 | MELK | 0.38718480 |
| 122 | MAP3K11 | 0.38694691 |
| 123 | RPS6KC1 | 0.35127866 |
| 124 | RPS6KL1 | 0.35127866 |
| 125 | MAP2K6 | 0.34026657 |
| 126 | KSR1 | 0.33969543 |
| 127 | FES | 0.33587800 |
| 128 | DAPK2 | 0.32384179 |
| 129 | PDPK1 | 0.31717798 |
| 130 | PDK1 | 0.29746932 |
| 131 | AKT3 | 0.29365573 |
| 132 | MAP3K6 | 0.27514701 |
| 133 | MARK2 | 0.27084844 |
| 134 | RPS6KA6 | 0.26428974 |
| 135 | MAP3K9 | 0.26057028 |
| 136 | RPS6KA2 | 0.22013239 |
| 137 | PKN1 | 0.21951590 |
| 138 | MAP3K2 | 0.20832395 |
| 139 | TEC | 0.20677449 |
| 140 | PRKAA2 | 0.20275122 |
| 141 | RPS6KA1 | 0.20011503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 3.10806151 |
| 2 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.92240525 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.73498914 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.56190666 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42263925 |
| 6 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.38612201 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30590267 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.24520325 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22703147 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.17933375 |
| 11 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11906093 |
| 12 | Salmonella infection_Homo sapiens_hsa05132 | 2.04759981 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00656906 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.84059656 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 1.83940293 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82804465 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81742357 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.76292412 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.73759610 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73210428 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62351852 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61001216 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.60813880 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.60088237 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59145137 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58871735 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.57537744 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57481327 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57407568 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.56047125 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.50654511 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47345868 |
| 33 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.47284338 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43967070 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.43316097 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34428672 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.31852793 |
| 38 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.21719591 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21706109 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.19595489 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.17025143 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.15143701 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08484322 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04614164 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04081731 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03811405 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02983826 |
| 48 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.01575295 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97603266 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.94862968 |
| 51 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94343503 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92943523 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92393786 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.91805385 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88818792 |
| 56 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88010076 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87920194 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85657101 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82747492 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.82245041 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.81419448 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81286509 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81202683 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.80268428 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78514061 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78380050 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77755821 |
| 68 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.75772762 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70230708 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69949422 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68456741 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64260576 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62653484 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61586730 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59581930 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58212844 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57635124 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57009498 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56354174 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.55858170 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.55571615 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55311565 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53627137 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52659892 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50957338 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49452111 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48145481 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47197570 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46989260 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46380999 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46294702 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46207448 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45496810 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45126040 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42970873 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.42453310 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41423485 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39326830 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39116899 |
| 100 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38398936 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.38250455 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37508814 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34955773 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34153779 |
| 105 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.33360042 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32920042 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32865216 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32126269 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31574664 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.30913627 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27489324 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24759054 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.24195884 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24071955 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22255010 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21620131 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21513989 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16138265 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16097625 |

